Subscribe
Magazine
Past Issues
Surveys
Industry Statistics
About Us
Members Only
Best Places to Work
General Interest
Exploration & Development
Drilling & Production
Refining & Processing
Pipelines & Transportation
LNG
Energy Transition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
PennEnergy Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Rafael Holdings Inc
(NY:
RFL
)
1.360
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
1.360
Bid (Size)
1.210 (1)
Ask (Size)
1.370 (7)
Prev. Close
1.360
Today's Range
1.360 - 1.360
52wk Range
1.290 - 2.360
Shares Outstanding
100
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
RFL Stock Earnings: Rafael Holdings Reported Results for Q3 2024
June 14, 2024
Rafael Holdings just reported results for the third quarter of 2024.
Via
InvestorPlace
Rafael Holdings Reports Third Quarter Fiscal 2024 Financial Results
June 14, 2024
Strategically focused on generating shareholder value by advancing our portfolio and identifying attractive investment opportunities with substantive upside potential
From
Rafael Holdings, Inc.
Via
GlobeNewswire
Performance
YTD
-25.68%
-25.68%
1 Month
-8.11%
-8.11%
3 Month
-17.07%
-17.07%
6 Month
-25.68%
-25.68%
1 Year
-38.46%
-38.46%
More News
Read More
Cyclo Therapeutics Achieves Landmark Milestone with Completion of Enrollment of Last Patient in Phase 3 Pivotal TransportNPC™ Trial of Niemann-Pick Type C1
May 30, 2024
From
Cyclo Therapeutics, Inc.
Via
Business Wire
Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results
March 13, 2024
From
Rafael Holdings, Inc.
Via
GlobeNewswire
RFL Stock Earnings: Rafael Holdings Reported Results for Q1 2024
December 14, 2023
Via
InvestorPlace
Rafael Holdings Reports First Quarter Fiscal 2024 Financial Results
December 14, 2023
From
Rafael Holdings, Inc.
Via
GlobeNewswire
Cyclo Therapeutics Reports Third Quarter 2023 Financial Results
November 15, 2023
From
Cyclo Therapeutics, Inc.
Via
Business Wire
Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results
October 30, 2023
From
Rafael Holdings, Inc.
Via
GlobeNewswire
Cyclo Therapeutics Reports Second Quarter 2023 Financial Results
August 15, 2023
From
Cyclo Therapeutics, Inc.
Via
Business Wire
Cyclo Therapeutics Announces Closing of $5.0 Million Private Placement with Rafael Holdings, Inc.
August 02, 2023
From
Cyclo Therapeutics, Inc.
Via
Business Wire
Rafael Holdings Reports Third Quarter Fiscal 2023 Financial Results and Provides Business Update
June 13, 2023
From
Rafael Holdings, Inc.
Via
GlobeNewswire
Cyclo Therapeutics Announces Execution of Definitive Agreement with Rafael Holdings, Inc. Providing for $5.0 Million of Additional Funding Via a Private Placement
June 05, 2023
From
Cyclo Therapeutics, Inc.
Via
Business Wire
Cyclo Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results
May 15, 2023
From
Cyclo Therapeutics, Inc.
Via
Business Wire
Cyclo Therapeutics Announces Closing of Strategic Investment Through a $2.1 Million Private Placement from Rafael Holdings, Inc. (NYSE:RFL)
May 02, 2023
From
Cyclo Therapeutics, Inc.
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
April 26, 2023
Via
InvestorPlace
Rafael Holdings Announces up to $5 Million Share Repurchase Program
April 04, 2023
From
Rafael Holdings, Inc.
Via
GlobeNewswire
Rafael Holdings Reports Second Quarter Fiscal 2023 Financial Results
March 14, 2023
From
Rafael Holdings, Inc.
Via
GlobeNewswire
Top Real Estate Stocks That May Plunge
February 17, 2023
Via
Benzinga
Rafael Holdings Reports First Quarter Fiscal 2023 Financial Results
December 13, 2022
From
Rafael Holdings, Inc.
Via
GlobeNewswire
Rafael Holdings to Focus on Strategic Business Development Initiatives and Curtail Early Stage Development Activities
November 15, 2022
From
Rafael Holdings, Inc.
Via
GlobeNewswire
Rafael Holdings Reports Fourth Quarter Fiscal 2022 Financial Results
October 31, 2022
From
Rafael Holdings, Inc.
Via
GlobeNewswire
Cornerstone Pharmaceuticals Initiates Phase 1 Trial of CPI-613® (devimistat) in Combination with Chemoradiation for the Treatment of Advanced Pancreatic Cancer
September 28, 2022
From
Cornerstone Pharmaceuticals
Via
GlobeNewswire
Alibaba, Zoom Video And 76 Biggest Movers From Yesterday
July 12, 2022
Via
Benzinga
Why These Casino Stocks Are Moving Lower, Here's 45 Stocks Moving In Monday's Mid-Day Session
July 11, 2022
Via
Benzinga
More Than $27 Million Bet On Seres Therapeutics? 4 Penny Stocks Insiders are Buying
July 08, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.